• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On PRAN

    Prana Biotechnology Limited (PRAN)

    -NasdaqCM
    1.54 Up 0.03(1.99%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:1.51
    Open:1.51
    Bid:N/A
    Ask:1.71 x 600
    1y Target Est:3.00
    Beta:-0.47
    Next Earnings Date:N/A
    Day's Range:1.47 - 1.60
    52wk Range:1.36 - 12.50
    Volume:250,739
    Avg Vol (3m):290,897
    Market Cap:78.34M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PRANUp 1.99%78.34M
    JNJDown 2.19%280.30B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.81
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Prana Biotechnology Limited develops therapies for the treatment of neurodegenerative diseases in Australia. The company focuses on the Alzheimer‘s and Huntington‘s diseases, as well as other age-related degeneration disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback